» Articles » PMID: 34563640

Incidence, Mortality, Survival, Risk Factor and Screening of Colorectal Cancer: A Comparison Among China, Europe, and Northern America

Overview
Journal Cancer Lett
Specialty Oncology
Date 2021 Sep 26
PMID 34563640
Citations 144
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer (CRC) is one of the most common malignancies worldwide. China, Europe and northern America account for more than half of the new CRC cases and associated deaths globally. This review summarizes the current status and temporal trends of CRC in China, Europe, and northern America. The potential primary preventive strategies and latest advances in CRC screening techniques and programs are discussed. Recently, the incidence and mortality of CRC in some European and northern American countries have decreased; conversely, CRC incidence and mortality continue to increase in China. The overall 5-year relative survival rate for CRC is similar between these regions, but there is considerable heterogeneity among European countries. Implementing population-based CRC screening programs can effectively address the growing disease burden. The effectiveness of nationwide CRC screening programs in these regions has been limited by relatively low coverage and participation rate. The deployment of state-of-the-art techniques and precise risk-adapted screening strategies incorporating effective risk prediction models and screening techniques may boost screening effectiveness. Our review provides novel foundations for the development and optimization of CRC preventive strategies.

Citing Articles

Global, Regional, and National Disease Burden and Prediction Analysis of Colorectal Cancer Attributable to Tobacco, Alcohol, and Obesity From 1990 to 2030.

Deng Y, Wang Y, Yang J, Luo X, Qiu J, Long R Front Oncol. 2025; 15:1524308.

PMID: 40078186 PMC: 11896864. DOI: 10.3389/fonc.2025.1524308.


High expression of stearoyl-coenzyme A desaturase in colorectal cancer oncogenic functions and its potential as a therapeutic target.

Wang X, Huang W, Qin K, Zeng D, Chen Z, Chi B World J Gastrointest Surg. 2025; 17(2):100237.

PMID: 40061980 PMC: 11885988. DOI: 10.4240/wjgs.v17.i2.100237.


Association between surrogate indices of fatty liver and the risk of colorectal cancer: a cross-sectional United States study.

Shi C, Yuan C, Hao Y, Zhou Z, Zhang Y Transl Cancer Res. 2025; 14(1):313-326.

PMID: 39974378 PMC: 11833385. DOI: 10.21037/tcr-24-1444.


Impact of dipeptidyl peptidase-4 inhibitors on incidence of colorectal cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Fu R, Chen J, Fang Y, Wu Q, Zhang X, Wang Z Ther Adv Drug Saf. 2025; 16:20420986251318842.

PMID: 39974280 PMC: 11837066. DOI: 10.1177/20420986251318842.


Patient-Derived Tumor Organoids: A Platform for Precision Therapy of Colorectal Cancer.

Li Y, Wu W, Yao J, Wang S, Wu X, Yan J Cell Transplant. 2025; 34:9636897251314645.

PMID: 39953837 PMC: 11829288. DOI: 10.1177/09636897251314645.